Sunitinib paves the way for targeted therapies in neuroendocrine tumors
✍ Scribed by Eric Raymond; Sandrine Faivre; Pascal Hammel; Philippe Ruszniewski
- Book ID
- 107384370
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 59 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1776-2596
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract Glioblastoma (GBM), the highest‐grade form of gliomas, is the most frequent and the most aggressive. Recently, a subpopulation of cells with stem cells characteristics, commonly named “tumor‐initiating stem cells” (TISCs) or “cancer stem cells” (CSCs) were identified in GBM. These cells
## Abstract Despite the fact that expression of Fas ligand (FasL) in cytotoxic T lymphocytes (CTLs) and in natural killer (NK) cells plays an important role in Fas‐mediated tumor killing, During tumor progression FasL‐expressing tumor cells are involved in __counterattacking__ to kill tumor‐infiltr